PLK1 (polo like kinase 1) inhibits MTOR complex 1 and promotes autophagy

References

• Strebhardt K, Becker S, Matthess Y. Thoughts on the current assessment of Polo-like kinase inhibitor drug discovery. Expert Opin Drug Discov 2015; 10:1-8; PMID:25263688; http://dx.doi.org/10.1517/17460441.2015.962510
   PubMed Web of Science ®Google Scholar
• Archambault V, Lepine G, Kachaner D. Understanding the polo kinase machine. Oncogene 2015; 34(37):4799-807; PMID:25619835
   PubMed Web of Science ®Google Scholar
• Zitouni S, Nabais C, Jana SC, Guerrero A, Bettencourt-Dias M. Polo-like kinases: structural variations lead to multiple functions. Nat Rev Mol Cell Biol 2014; 15:433-52; PMID:24954208; http://dx.doi.org/10.1038/nrm3819
   PubMed Web of Science ®Google Scholar
• Craig SN, Wyatt MD, McInnes C. Current assessment of polo-like kinases as anti-tumor drug targets. Expert Opin Drug Discov 2014; 9:773-89; PMID:24819909; http://dx.doi.org/10.1517/17460441.2014.918100
   PubMed Web of Science ®Google Scholar
• Steegmaier M, Hoffmann M, Baum A, Lénárt P, Petronczki M, Krššák M, Gürtler U, Garin-Chesa P, Lieb S, Quant J, et al. BI 2536, a potent and selective inhibitor of Polo-like kinase 1, inhibits tumor growth in vivo. Curr Biol 2007; 17:316-22; PMID:17291758; http://dx.doi.org/10.1016/j.cub.2006.12.037
   PubMed Web of Science ®Google Scholar
• Lens SM, Voest EE, Medema RH. Shared and separate functions of polo-like kinases and aurora kinases in cancer. Nat Rev Cancer 2010; 10:825-41; PMID:21102634; http://dx.doi.org/10.1038/nrc2964
   PubMed Web of Science ®Google Scholar
• Degenhardt Y, Lampkin T. Targeting Polo-like Kinase in Cancer Therapy. Clin Cancer Res 2010; 16:384-9; PMID:20068088; http://dx.doi.org/10.1158/1078-0432.CCR-09-1380
   PubMed Web of Science ®Google Scholar
• Cargnello M, Tcherkezian J, Roux PP. The expanding role of mTOR in cancer cell growth and proliferation. Mutagenesis 2015; 30:169-76; PMID:25688110; http://dx.doi.org/10.1093/mutage/geu045
   PubMed Web of Science ®Google Scholar
• Chiarini F, Evangelisti C, McCubrey JA, Martelli AM. Current treatment strategies for inhibiting mTOR in cancer. Trends Pharmacol Sci 2015; 36:124-35; PMID:25497227; http://dx.doi.org/10.1016/j.tips.2014.11.004
   PubMed Web of Science ®Google Scholar
• Shimobayashi M, Hall MN. Making new contacts: the mTOR network in metabolism and signalling crosstalk. Nat Rev Mol Cell Biol 2014; 15:155-62; PMID:24556838; http://dx.doi.org/10.1038/nrm3757
   PubMed Web of Science ®Google Scholar
• Bar-Peled L, Sabatini DM. Regulation of mTORC1 by amino acids. Trends Cell Biol 2014; 24:400-6; PMID:24698685; http://dx.doi.org/10.1016/j.tcb.2014.03.003
   PubMed Web of Science ®Google Scholar
• Laplante M, Sabatini DM. mTOR signaling in growth control and disease. Cell 2012; 149:274-93; PMID:22500797; http://dx.doi.org/10.1016/j.cell.2012.03.017
   PubMed Web of Science ®Google Scholar
• Thoreen CC, Kang SA, Chang JW, Liu Q, Zhang J, Gao Y, Reichling LJ, Sim T, Sabatini DM, Gray NS. An ATP-competitive Mammalian Target of Rapamycin Inhibitor Reveals Rapamycin-resistant Functions of mTORC1. J Biol Chem 2009; 284:8023-32; PMID:19150980; http://dx.doi.org/10.1074/jbc.M900301200
   PubMed Web of Science ®Google Scholar
• Sancak Y, Bar-Peled L, Zoncu R, Markhard AL, Nada S, Sabatini DM. Ragulator-Rag Complex Targets mTORC1 to the Lysosomal Surface and Is Necessary for Its Activation by Amino Acids. Cell 2010; 141:290-303; PMID:20381137; http://dx.doi.org/10.1016/j.cell.2010.02.024
   PubMed Web of Science ®Google Scholar
• Sancak Y, Peterson TR, Shaul YD, Lindquist RA, Thoreen CC, Bar-Peled L, Sabatini DM. The Rag GTPases Bind Raptor and Mediate Amino Acid Signaling to mTORC1. Science 2008; 320:1496-501; PMID:18497260; http://dx.doi.org/10.1126/science.1157535
   PubMed Web of Science ®Google Scholar
• Demetriades C, Doumpas N, Teleman Aurelio A. Regulation of TORC1 in Response to Amino Acid Starvation via Lysosomal Recruitment of TSC2. Cell 2014; 156:786-99; PMID:24529380; http://dx.doi.org/10.1016/j.cell.2014.01.024
   PubMed Web of Science ®Google Scholar
• Betz C, Hall MN. Where is mTOR and what is it doing there? J Cell Biol 2013; 203:563-74; PMID:24385483; http://dx.doi.org/10.1083/jcb.201306041
   PubMed Web of Science ®Google Scholar
• Laplante M, Sabatini DM. Regulation of mTORC1 and its impact on gene expression at a glance. J Cell Sci 2013; 126:1713-9; PMID:23641065; http://dx.doi.org/10.1242/jcs.125773
   PubMed Web of Science ®Google Scholar
• Heberle AM, Prentzell MT, van Eunen K, Bakker BM, Grellscheid SN, Thedieck K. Molecular mechanisms of mTOR regulation by stress. Mol Cell Oncol 2015; 2:e970489; PMID:27308421; http://dx.doi.org/10.4161/23723548.2014.970489
   PubMed Web of Science ®Google Scholar
• Howell JJ, Ricoult SJ, Ben-Sahra I, Manning BD. A growing role for mTOR in promoting anabolic metabolism. Biochem Soc Trans 2013; 41:906-12; PMID:23863154; http://dx.doi.org/10.1042/BST20130041
   PubMed Web of Science ®Google Scholar
• Chauvin C, Koka V, Nouschi A, Mieulet V, Hoareau-Aveilla C, Dreazen A, Cagnard N, Carpentier W, Kiss T, Meyuhas O, et al. Ribosomal protein S6 kinase activity controls the ribosome biogenesis transcriptional program. Oncogene 2014; 33:474-83; PMID:23318442; http://dx.doi.org/10.1038/onc.2012.606
   PubMed Web of Science ®Google Scholar
• Renner AG, Creancier L, Dos Santos C, Fialin C, Recher C, Bailly C, Kruczynski A, Payrastre B, Manenti S. A functional link between polo-like kinase 1 and the mammalian target-of-rapamycin pathway? Cell Cycle 2010; 9:1690-6; PMID:20404504; http://dx.doi.org/10.4161/cc.9.9.11295
   PubMed Web of Science ®Google Scholar
• Astrinidis A, Senapedis W, Henske EP. Hamartin, the tuberous sclerosis complex 1 gene product, interacts with polo-like kinase 1 in a phosphorylation-dependent manner. Hum Mol Genet 2006; 15:287-97; PMID:16339216; http://dx.doi.org/10.1093/hmg/ddi444
   PubMed Web of Science ®Google Scholar
• Zhang Z, Hou X, Shao C, Li J, Cheng J-X, Kuang S, Ahmad N, Ratliff T, Liu X. Plk1 Inhibition Enhances the Efficacy of Androgen Signaling Blockade in Castration-Resistant Prostate Cancer. Cancer Res 2014; 74:6635-47; PMID:25252916; http://dx.doi.org/10.1158/0008-5472.CAN-14-1916
   PubMed Web of Science ®Google Scholar
• Li Z, Li J, Bi P, Lu Y, Burcham G, Elzey BD, Ratliff T, Konieczny SF, Ahmad N, Kuang S, et al. Plk1 Phosphorylation of PTEN Causes a Tumor-Promoting Metabolic State. Mol Cell Biol 2014; 34:3642-61; PMID:25047839; http://dx.doi.org/10.1128/MCB.00814-14
   PubMed Web of Science ®Google Scholar
• Spartà AM, Bressanin D, Chiarini F, Lonetti A, Cappellini A, Evangelisti C, Evangelisti C, Melchionda F, Pession A, Bertaina A, et al. Therapeutic targeting of Polo-like kinase-1 and Aurora kinases in T-cell acute lymphoblastic leukemia. Cell Cycle 2014; 13:2237-47; PMID:24874015; http://dx.doi.org/10.4161/cc.29267
   PubMed Web of Science ®Google Scholar
• Hansen M, Hsu AL, Dillin A, Kenyon C. New genes tied to endocrine, metabolic, and dietary regulation of lifespan from a Caenorhabditis elegans genomic RNAi screen. PLoS Genet 2005; 1:119-28; PMID:16103914; http://dx.doi.org/10.1371/journal.pgen.0010017
   PubMed Web of Science ®Google Scholar
• Feng Y, Yao Z, Klionsky DJ. How to control self-digestion: transcriptional, post-transcriptional, and post-translational regulation of autophagy. Trends Cell Biol 2015; 25:354-63; PMID:25759175; http://dx.doi.org/10.1016/j.tcb.2015.02.002
   PubMed Web of Science ®Google Scholar
• Kaur J, Debnath J. Autophagy at the crossroads of catabolism and anabolism. Nat Rev Mol Cell Biol 2015; 16:461-72; PMID:26177004; http://dx.doi.org/10.1038/nrm4024
   PubMed Web of Science ®Google Scholar
• Feng Y, He D, Yao Z, Klionsky DJ. The machinery of macroautophagy. Cell Res 2014; 24:24-41; PMID:24366339; http://dx.doi.org/10.1038/cr.2013.168
   PubMed Web of Science ®Google Scholar
• Yang Z, Klionsky DJ. Eaten alive: a history of macroautophagy. Nat Cell Biol 2010; 12:814-22; PMID:20811353; http://dx.doi.org/10.1038/ncb0910-814
   PubMed Web of Science ®Google Scholar
• Rebecca VW, Amaravadi RK. Emerging strategies to effectively target autophagy in cancer. Oncogene 2015; 35(1):1-11; PMID:25893285
   PubMed Web of Science ®Google Scholar
• Kim YC, Guan KL. mTOR: a pharmacologic target for autophagy regulation. J Clin Invest 2015; 125:25-32; PMID:25654547; http://dx.doi.org/10.1172/JCI73939
   PubMed Web of Science ®Google Scholar
• Duffy A, Le J, Sausville E, Emadi A. Autophagy modulation: a target for cancer treatment development. Cancer Chemother Pharmacol 2015; 75:439-47; PMID:25422156; http://dx.doi.org/10.1007/s00280-014-2637-z
   PubMed Web of Science ®Google Scholar
• Klionsky DJ, Abdalla FC, Abeliovich H, Abraham RT, Acevedo-Arozena A, Adeli K, Agholme L, Agnello M, Agostinis P, Aguirre-Ghiso JA, et al. Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy 2012; 8:445-544; PMID:22966490; http://dx.doi.org/10.4161/auto.19496
   PubMed Web of Science ®Google Scholar
• Eskelinen EL, Prescott AR, Cooper J, Brachmann SM, Wang L, Tang X, Backer JM, Lucocq JM. Inhibition of autophagy in mitotic animal cells. Traffic 2002; 3:878-93; PMID:12453151; http://dx.doi.org/10.1034/j.1600-0854.2002.31204.x
   PubMed Web of Science ®Google Scholar
• Furuya T, Kim M, Lipinski M, Li J, Kim D, Lu T, Shen Y, Rameh L, Yankner B, Tsai LH, et al. Negative Regulation of Vps34 by Cdk Mediated Phosphorylation. Mol Cell 2010; 38:500-11; PMID:20513426; http://dx.doi.org/10.1016/j.molcel.2010.05.009
   PubMed Web of Science ®Google Scholar
• Golsteyn RM, Schultz SJ, Bartek J, Ziemiecki A, Ried T, Nigg EA. Cell cycle analysis and chromosomal localization of human Plk1, a putative homologue of the mitotic kinases Drosophila polo and Saccharomyces cerevisiae Cdc5. J Cell Sci 1994; 107:1509-17; PMID:7962193
   PubMed Web of Science ®Google Scholar
• Valianou M, Cox AM, Pichette B, Hartley S, Paladhi UR, Astrinidis A. Pharmacological inhibition of Polo-like kinase 1 (PLK1) by BI-2536 decreases the viability and survival of hamartin and tuberin deficient cells via induction of apoptosis and attenuation of autophagy. Cell Cycle 2015; 14:399-407; PMID:25565629; http://dx.doi.org/10.4161/15384101.2014.986394
   PubMed Web of Science ®Google Scholar
• Deeraksa A, Pan J, Sha Y, Liu XD, Eissa NT, Lin SH, Yu-Lee LY. Plk1 is upregulated in androgen-insensitive prostate cancer cells and its inhibition leads to necroptosis. Oncogene 2013; 32:2973-83; PMID:22890325; http://dx.doi.org/10.1038/onc.2012.309
   PubMed Web of Science ®Google Scholar
• Inwald EC, Klinkhammer-Schalke M, Hofstädter F, Zeman F, Koller M, Gerstenhauer M, Ortmann O. Ki-67 is a prognostic parameter in breast cancer patients: results of a large population-based cohort of a cancer registry. Breast Cancer Res Treat 2013; 139:539-52; PMID:23674192; http://dx.doi.org/10.1007/s10549-013-2560-8
   PubMed Web of Science ®Google Scholar
• Palm W, Park Y, Wright K, Pavlova Natalya N, Tuveson David A, Thompson Craig B. The Utilization of Extracellular Proteins as Nutrients Is Suppressed by mTORC1. Cell 2015; 162:259-70; PMID:26144316; http://dx.doi.org/10.1016/j.cell.2015.06.017
   PubMed Web of Science ®Google Scholar
• Schwarz JJ, Wiese H, Toelle RC, Zarei M, Dengjel J, Warscheid B, Thedieck K. Functional proteomics identifies acinus L as a direct insulin- and amino acid-dependent mTORC1 substrate. Mol Cell Proteomics 2015; 14:2042-55; http://dx.doi.org/10.1074/mcp.M114.045807
   PubMed Web of Science ®Google Scholar
• Shao T, Liu X. Identification of Rictor as a Novel Substrate of Polo-like kinase 1. Cell Cycle 2015; 14:755-60; PMID:25714006; http://dx.doi.org/10.1080/15384101.2014.998050
   PubMed Web of Science ®Google Scholar
• Dalle Pezze P, Sonntag AG, Thien A, Prentzell MT, Gödel M, Fischer S, Neumann-Haefelin E, Huber TB, Baumeister R, Shanley DP, et al. A dynamic network model of mTOR signaling reveals TSC-Independent mTORC2 regulation. Sci Signal 2012; 5(217):ra25.
   PubMed Web of Science ®Google Scholar
• van Vugt MA, van de Weerdt BC, Vader G, Janssen H, Calafat J, Klompmaker R, Wolthuis RM, Medema RH. Polo-like Kinase-1 Is Required for Bipolar Spindle Formation but Is Dispensable for Anaphase Promoting Complex/Cdc20 Activation and Initiation of Cytokinesis. J Biol Chem 2004; 279:36841-54; PMID:15210710; http://dx.doi.org/10.1074/jbc.M313681200
   PubMed Web of Science ®Google Scholar
• Sumara I, Giménez-Abián JF, Gerlich D, Hirota T, Kraft C, de la Torre C, Ellenberg J, Peters JM. Roles of Polo-like Kinase 1 in the Assembly of Functional Mitotic Spindles. Curr Biol 2004; 14:1712-22; PMID:15458642; http://dx.doi.org/10.1016/j.cub.2004.09.049
   PubMed Web of Science ®Google Scholar
• Magnuson B, Ekim B, Fingar DC. Regulation and function of ribosomal protein S6 kinase (S6K) within mTOR signalling networks. Biochem J 2012; 441:1-21; PMID:22168436; http://dx.doi.org/10.1042/BJ20110892
   PubMed Web of Science ®Google Scholar
• Ramírez-Valle F, Badura ML, Braunstein S, Narasimhan M, Schneider RJ. Mitotic raptor promotes mTORC1 activity, G(2)/M cell cycle progression, and internal ribosome entry site-mediated mRNA translation. Mol Cell Biol 2010; 30:3151-64; PMID:20439490; http://dx.doi.org/10.1128/MCB.00322-09
   PubMed Web of Science ®Google Scholar
• Shah OJ, Ghosh S, Hunter T. Mitotic regulation of ribosomal S6 kinase 1 involves Ser/Thr, Pro phosphorylation of consensus and Non-consensus sites by Cdc2. J Biol Chem 2003; 278:16433-42; PMID:12586835; http://dx.doi.org/10.1074/jbc.M300435200
   PubMed Web of Science ®Google Scholar
• Hara K, Maruki Y, Long X, Yoshino K, Oshiro N, Hidayat S, Tokunaga C, Avruch J, Yonezawa K. Raptor, a binding partner of target of rapamycin (TOR), mediates TOR action. Cell 2002; 110:177-89; PMID:12150926; http://dx.doi.org/10.1016/S0092-8674(02)00833-4
   PubMed Web of Science ®Google Scholar
• Kim DH, Sarbassov DD, Ali SM, King JE, Latek RR, Erdjument-Bromage H, Tempst P, Sabatini DM. mTOR interacts with raptor to form a nutrient-sensitive complex that signals to the cell growth machinery. Cell 2002; 110:163-75; PMID:12150925; http://dx.doi.org/10.1016/S0092-8674(02)00808-5
   PubMed Web of Science ®Google Scholar
• Carrière A, Cargnello M, Julien L-A, Gao H, Bonneil É, Thibault P, Roux PP. Oncogenic MAPK signaling stimulates mTORC1 activity by promoting RSK-mediated raptor phosphorylation. Curr Biol 2008; 18:1269-77; PMID:18722121; http://dx.doi.org/10.1016/j.cub.2008.07.078
   PubMed Web of Science ®Google Scholar
• Preisinger C, Körner R, Wind M, Lehmann WD, Kopajtich R, Barr FA. Plk1 docking to GRASP65 phosphorylated by Cdk1 suggests a mechanism for Golgi checkpoint signalling. EMBO J 2005; 24(4):753-65
   PubMed Web of Science ®Google Scholar
• Zhou X, Clister Terri L, Lowry Pamela R, Seldin Marcus M, Wong GW, Zhang J. Dynamic visualization of mTORC1 activity in living cells. Cell Rep 2015; 10:1767-77; http://dx.doi.org/10.1016/j.celrep.2015.02.031
   PubMed Web of Science ®Google Scholar
• Thomas Janice D, Zhang YJ, Wei YH, Cho JH, Morris Laura E, Wang HY, Zheng XF. Rab1A Is an mTORC1 activator and a colorectal oncogene. Cancer Cell 2014; 26:754-69; PMID:25446900; http://dx.doi.org/10.1016/j.ccell.2014.09.008
   PubMed Web of Science ®Google Scholar
• Strebhardt K. Multifaceted polo-like kinases: drug targets and antitargets for cancer therapy. Nat Rev Drug Discov 2010; 9:643-60; PMID:20671765; http://dx.doi.org/10.1038/nrd3184
   PubMed Web of Science ®Google Scholar
• Menon S, Dibble Christian C, Talbott G, Hoxhaj G, Valvezan Alexander J, Takahashi H, Cantley Lewis C, Manning Brendan D. Spatial control of the TSC complex integrates insulin and nutrient regulation of mTORC1 at the lysosome. Cell 2014; 156:771-85; PMID:24529379; http://dx.doi.org/10.1016/j.cell.2013.11.049
   PubMed Web of Science ®Google Scholar
• Smits VAJ, Klompmaker R, Arnaud L, Rijksen G, Nigg EA, Medema RH. Polo-like kinase-1 is a target of the DNA damage checkpoint. Nat Cell Biol 2000; 2:672-6; PMID:10980711; http://dx.doi.org/10.1038/35023629
   PubMed Web of Science ®Google Scholar
• Mizushima N, Yoshimori T, Levine B. Methods in Mammalian Autophagy Research. Cell 2010; 140:313-26
   PubMed Web of Science ®Google Scholar
• Kimura S, Noda T, Yoshimori T. Dissection of the autophagosome maturation process by a novel reporter protein, tandem fluorescent-tagged LC3. Autophagy 2007; 3:452-60; PMID:17534139; http://dx.doi.org/10.4161/auto.4451
   PubMed Web of Science ®Google Scholar
• Szyniarowski P, Corcelle-Termeau E, Farkas T, Høyer-Hansen M, Nylandsted J, Kallunki T, Jäättelä M. A comprehensive siRNA screen for kinases that suppress macroautophagy in optimal growth conditions. Autophagy 2011; 7:892-903; PMID:21508686; http://dx.doi.org/10.4161/auto.7.8.15770
   PubMed Web of Science ®Google Scholar
• Hong Y, Roy R, Ambros V. Developmental regulation of a cyclin-dependent kinase inhibitor controls postembryonic cell cycle progression in Caenorhabditis elegans. Development 1998; 125:3585-97; PMID:9716524
   PubMed Web of Science ®Google Scholar
• Egan DF, Shackelford DB, Mihaylova MM, Gelino S, Kohnz RA, Mair W, Vasquez DS, Joshi A, Gwinn DM, Taylor R, et al. Phosphorylation of ULK1 (hATG1) by AMP-Activated Protein Kinase Connects Energy Sensing to Mitophagy. Science 2011; 331:456-61; PMID:21205641; http://dx.doi.org/10.1126/science.1196371
   PubMed Web of Science ®Google Scholar
• Melendez A, Talloczy Z, Seaman M, Eskelinen EL, Hall DH, Levine B. Autophagy genes are essential for dauer development and life-span extension in C. elegans. Science 2003; 301:1387-91.
   PubMed Web of Science ®Google Scholar
• Lu Q, Yang P, Huang X, Hu W, Guo B, Wu F, Lin L, Kovács Attila L, Yu L, Zhang H. The WD40 Repeat PtdIns(3)P-Binding Protein EPG-6 Regulates Progression of Omegasomes to Autophagosomes. Dev Cell 2011; 21:343-57; PMID:21802374; http://dx.doi.org/10.1016/j.devcel.2011.06.024
   PubMed Web of Science ®Google Scholar
• Bibi N, Parveen Z, Rashid S. Identification of Potential Plk1 Targets in a Cell-Cycle Specific Proteome through Structural Dynamics of Kinase and Polo Box-Mediated Interactions. PLoS One 2013; 8:e70843; PMID:23967120; http://dx.doi.org/10.1371/journal.pone.0070843
   PubMed Web of Science ®Google Scholar
• Santamaria A, Wang B, Elowe S, Malik R, Zhang F, Bauer M, Schmidt A, Silljé HH, Körner R, Nigg EA. The Plk1-dependent phosphoproteome of the early mitotic spindle. Mol Cell Proteomics 2011; 10:M110; http://dx.doi.org/10.1074/mcp.M110.004457
   PubMed Web of Science ®Google Scholar
• Grosstessner-Hain K, Hegemann B, Novatchkova M, Rameseder J, Joughin BA, Hudecz O, Roitinger E, Pichler P, Kraut N, Yaffe MB, et al. Quantitative phospho-proteomics to investigate the polo-like kinase 1-dependent phospho-proteome. Mol Cell Proteomics 2011; 10:M111; http://dx.doi.org/10.1074/mcp.M111.008540
   PubMed Web of Science ®Google Scholar
• Foster KG, Acosta-Jaquez HA, Romeo Y, Ekim B, Soliman GA, Carriere A, Roux PP, Ballif BA, Fingar DC. Regulation of mTOR complex 1 (mTORC1) by raptor Ser863 and multisite phosphorylation. J Biol Chem 2010; 285:80-94; PMID:19864431; http://dx.doi.org/10.1074/jbc.M109.029637
   PubMed Web of Science ®Google Scholar
• Ono Y, Kinouchi T, Sorimachi H, Ishiura S, Suzuki K. Deletion of an endosomal/lysosomal targeting signal promotes the secretion of alzheimer's disease amyloid precursor protein (APP). J Biochem 1997; 121:585-90; PMID:9133629; http://dx.doi.org/10.1093/oxfordjournals.jbchem.a021625
   PubMed Web of Science ®Google Scholar
• Yim H. Current clinical trials with polo-like kinase 1 inhibitors in solid tumors. Anticancer Drugs 2013; 24:999-1006; PMID:23949254; http://dx.doi.org/10.1097/CAD.0000000000000007
   PubMed Web of Science ®Google Scholar
• Tan J, Li Z, Lee PL, Guan P, Aau MY, Lee ST, Feng M, Lim CZ, Lee EY, Wee ZN, et al. PDK1 signaling toward PLK1-MYC activation confers oncogenic transformation, tumor-initiating cell activation, and resistance to mTOR-targeted therapy. Cancer Discov 2013; 3:1156-71; PMID:23887393; http://dx.doi.org/10.1158/2159-8290.CD-12-0595
   PubMed Web of Science ®Google Scholar
• Thein KH, Kleylein-Sohn J, Nigg EA, Gruneberg U. Astrin is required for the maintenance of sister chromatid cohesion and centrosome integrity. J Cell Biol 2007; 178:345-54; PMID:17664331; http://dx.doi.org/10.1083/jcb.200701163
   PubMed Web of Science ®Google Scholar
• Brenner S. The genetics of Caenorhabditis elegans. Genetics 1974; 77:71-94; PMID:4366476
   PubMed Web of Science ®Google Scholar
• Rual JF, Ceron J, Koreth J, Hao T, Nicot AS, Hirozane-Kishikawa T, Vandenhaute J, Orkin SH, Hill DE, van den Heuvel S, et al. Toward improving caenorhabditis elegans phenome mapping with an ORFeome-based RNAi library. Genome Res 2004; 14:2162-8; PMID:15489339; http://dx.doi.org/10.1101/gr.2505604
   PubMed Web of Science ®Google Scholar
• Kamath RS, Fraser AG, Dong Y, Poulin G, Durbin R, Gotta M, Kanapin A, Le Bot N, Moreno S, Sohrmann M, et al. Systematic functional analysis of the Caenorhabditis elegans genome using RNAi. Nature 2003; 421:231-7; PMID:12529635; http://dx.doi.org/10.1038/nature01278
   PubMed Web of Science ®Google Scholar